These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38361962)

  • 1. Antifungal activity of green-synthesized curcumin-coated silver nanoparticles alone and in combination with fluconazole and itraconazole against
    Amini SM; I Getso M; Farahyar S; Khodavaisy S; Roudbary M; Pirhajati Mahabadi V; Mahmoudi S
    Curr Med Mycol; 2023 Sep; 9(3):38-44. PubMed ID: 38361962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal activity of curcumin-silver nanoparticles against fluconazole-resistant clinical isolates of
    Paul S; Mohanram K; Kannan I
    Ayu; 2018; 39(3):182-186. PubMed ID: 31000996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy Between Polyvinylpyrrolidone-Coated Silver Nanoparticles and Azole Antifungal Against Drug-Resistant Candida albicans.
    Sun L; Liao K; Li Y; Zhao L; Liang S; Guo D; Hu J; Wang D
    J Nanosci Nanotechnol; 2016 Mar; 16(3):2325-35. PubMed ID: 27455637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal Activity of Selenium Nanoparticles Synthesized by Bacillus species Msh-1 Against Aspergillus fumigatus and Candida albicans.
    Shakibaie M; Salari Mohazab N; Ayatollahi Mousavi SA
    Jundishapur J Microbiol; 2015 Sep; 8(9):e26381. PubMed ID: 26495111
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Sun Y; Tan L; Yao Z; Gao L; Yang J; Zeng T
    Microbiol Spectr; 2022 Feb; 10(1):e0200721. PubMed ID: 35019705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green Approach to Overcome the Resistance Pattern of Candida spp. Using Biosynthesized Silver Nanoparticles Fabricated by Penicillium chrysogenum F9.
    Soliman AM; Abdel-Latif W; Shehata IH; Fouda A; Abdo AM; Ahmed YM
    Biol Trace Elem Res; 2021 Feb; 199(2):800-811. PubMed ID: 32451695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green synthesis of silver nanoparticles using
    Mohammadi M; Shahisaraee SA; Tavajjohi A; Pournoori N; Muhammadnejad S; Mohammadi SR; Poursalehi R; Delavari H H
    IET Nanobiotechnol; 2019 Apr; 13(2):114-119. PubMed ID: 31051440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal drug resistance in pathogenic fungi.
    Vanden Bossche H; Dromer F; Improvisi I; Lozano-Chiu M; Rex JH; Sanglard D
    Med Mycol; 1998; 36 Suppl 1():119-28. PubMed ID: 9988500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of Nanoparticles Against Fluconazole-Resistant
    Lotfali E; Ghasemi R; Fattahi A; Keymaram M; Shafiei M; Norouzi M; Ayatollahi A
    Assay Drug Dev Technol; 2021; 19(8):501-507. PubMed ID: 34767723
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of Clinical Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution methods for determining the susceptibilities of Candida isolates].
    Dalyan Cilo B; Topaç T; Ağca H; Sağlam S; Efe K; Ener B
    Mikrobiyol Bul; 2018 Jan; 52(1):35-48. PubMed ID: 29642828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
    Karabıçak N; Alem N
    Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photo-induced green synthesis and antimicrobial efficacy of poly (ɛ-caprolactone)/curcumin/grape leaf extract-silver hybrid nanoparticles.
    El-Sherbiny IM; El-Shibiny A; Salih E
    J Photochem Photobiol B; 2016 Jul; 160():355-63. PubMed ID: 27183490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZnO, TiO2 and Ag nanoparticles impact against some species of pathogenic bacteria and yeast.
    Mohammed AK; Salh KK; Ali FA
    Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):24-34. PubMed ID: 34933736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent in vitro activity of curcumin and quercetin co-encapsulated in nanovesicles without hyaluronan against Aspergillus and Candida isolates.
    Sadeghi-Ghadi Z; Vaezi A; Ahangarkani F; Ilkit M; Ebrahimnejad P; Badali H
    J Mycol Med; 2020 Dec; 30(4):101014. PubMed ID: 32800427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antifungal activity of silver nanoparticles against ocular pathogenic filamentous fungi.
    Xu Y; Gao C; Li X; He Y; Zhou L; Pang G; Sun S
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):270-4. PubMed ID: 23410063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal Activity of Curcuminoids and Difluorinated Curcumin Against Clinical Isolates of Candida Species.
    Azari B; Zahmatkesh Moghadam S; Zarrinfar H; Tasbandi A; Jamialahmadi T; Sahebkar A
    Adv Exp Med Biol; 2021; 1328():123-129. PubMed ID: 34981474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
    Kan S; Song N; Pang Q; Mei H; Zheng H; Li D; Cui F; Lv G; An R; Li P; Xiong Z; Fan S; Zhang M; Chen Y; Qiao Q; Liang X; Cui M; Li D; Liao Q; Li X; Liu W
    Mycopathologia; 2023 Apr; 188(1-2):99-109. PubMed ID: 36378354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods.
    Pfaller MA; Boyken L; Hollis RJ; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2005 Aug; 43(8):3807-10. PubMed ID: 16081915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.